Conversation resumes after 19 years
After 19 years in a minimally conscious state, a man recovered language and motor function.
After 19 years in a minimally conscious state, a man recovered language and motor function. Diffusion tensor imaging showed reorganization of the patient's white matter, possibly facilitating functional recovery.
At the initial DTI evaluation by Henning U. Voss, Ph.D., a biomedical researcher at Cornell University, and colleagues, the patient already had regained limited movement, speech, and communication. DTI showed increased anisotropy (less water diffusion in white matter tracts, indicating recovery) in the medial parieto-occipital (MPO) areas compared with controls (J Clin Invest 2006;116:2005-2011).
Eighteen months later, at the time of a second scan, the patient's motor and cognitive functions had further improved. Interestingly, anisotropy in the MPO had decreased. Researchers theorize that the initial increase in anisotropy was a transitional stage of an ongoing axonal sprouting process. Once the new fiber tracts were laid down, anisotropy decreased as axons sprouted toward other targets.
FDA Clears Virtually Helium-Free 1.5T MRI System from Siemens Healthineers
June 26th 2025Offering a cost- and resource-saving DryCool magnet technology, the Magnetom Flow.Ace MRI system reportedly requires 0.7 liters of liquid helium for cooling over the lifetime of the device in contrast to over 1,000 liters commonly utilized with conventional MRI platforms.
Multinational Study Reaffirms Value of Adjunctive AI for Prostate MRI
June 16th 2025The use of adjunctive AI in biparametric prostate MRI exams led to 3.3 percent and 3.4 percent increases in the AUC and specificity, respectively, for clinically significant prostate cancer (csPCa) in a 360-person cohort drawn from 53 facilities.
FDA Clears Enhanced MRI-Guided Laser Ablation System
June 5th 2025An alternative to an open neurosurgical approach, the Visualase V2 MRI-Guided Laser Ablation System reportedly utilizes laser interstitial thermal therapy (LITT) for targeted soft tissue ablation in patients with brain tumors and focal epilepsy.
